References
National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008 [online]. Available from URL: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf [Accessed 2008 Jul 30]
Brazier J. Valuing health states for use in cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 769–779
Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 781–798
McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 2008; 26 (9): 733–744
Miners A. Estimating ‘costs’ for cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 745–751
Sculpher M. Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 799–806
Sutton A, Ades AE, Cooper N, et al, on behalf of the NICE Decision Support Unit. Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoeconomics 2008; 26 (9): 753–767
National Institute for Health and Clinical Excellence. Social value judgements: principles for the development of NICE guidance. 2nd ed [online]. Available from URL: http://www.nice.org.uk/media/998/50/SVJ2forpublicconsultation.pdf [Accessed 2008 Jul 30]
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Earnshaw, J., Lewis, G. NICE Guide to the Methods of Technology Appraisal . Pharmacoeconomics 26, 725–727 (2008). https://doi.org/10.2165/00019053-200826090-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-200826090-00002